Anti-PD-1 Antibody Therapy Induces Hashimoto’s Disease with an Increase in Peripheral Blood Follicular Helper T Cells

Safety, activity, and immune correlates of anti–PD-1 antibody in cancer

Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628 · see citing works

Follicular Helper CD4 T Cells (T _FH )

Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738 · see citing works

Role of CXCR5 and CCR7 in Follicular Th Cell Positioning and Appearance of a Programmed Cell Death Gene-1High Germinal Center-Associated Subpopulation

Haynes, N. M., Allen, C. D. C., Lesley, R., Ansel, K. M., Killeen, N. P., & Cyster, J. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5099 · Cited by 694 · see citing works

Increased Frequency of Follicular Helper T Cells in Patients with Autoimmune Thyroid Disease

Zhu, C., Ma, J., Liu, Y., Tong, J., Tian, J., Chen, J., Tang, X., Xu, H., Lu, L., & Wang, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2003 · Cited by 196 · see citing works

Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints

Chang, L., Barroso‐Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 545 · see citing works

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports

Tan, M. H., Iyengar, R., Mizokami-Stout, K., Yentz, S., MacEachern, M. P., Shen, L. Y., Redman, B., & Gianchandani, R. (2019) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-018-0073-4 · Cited by 172 · see citing works

Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study

Okada, N., Iwama, S., Okuji, T., Kobayashi, T., Yasuda, Y., Wada, E., Onoue, T., Goto, M., Sugiyama, M., Tsunekawa, T., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0736-7 · Cited by 78 · see citing works

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube‐Magg, C., Li, W., Makrypidi‐Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., et al. (2019) · Disease Markers · doi:10.1155/2019/5160565 · Cited by 75 · see citing works

Thyroid disorders induced by immune checkpoint inhibitors

Karaviti, D., Kani, E.-R., Karaviti, E., Gerontiti, E., Michalopoulou, O., Stefanaki, K., Kazakou, P., Vasileiou, V., Ψαλτοπούλου, Θ., & Paschou, S. Α. (2024) · Endocrine · doi:10.1007/s12020-024-03718-2 · Cited by 40 · see citing works

Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review)

Peiffert, M., Cugnet-Anceau, C., Dalle, S., Chikh, K., Assaad, S., Disse, E., Raverot, G., Borson-Chazot, F., & Abeillon-du Payrat, J. (2021) · Cancers · doi:10.3390/cancers13081944 · Cited by 33 · see citing works

The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries

Deligiorgi, M. V., Sagredou, S., Vakkas, L., & Trafalis, D. T. (2021) · Cancers · doi:10.3390/cancers13215277 · Cited by 22 · see citing works

Expressions of IL-17 and TNF-α in patients with Hashimoto’s disease combined with thyroid cancer before and after surgery and their relationship with prognosis

Zhang, N., Wang, Q., Tian, Y., Xiong, S., Li, G., & Xu, L. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02253-1 · Cited by 18 · see citing works

Common endocrine system adverse events associated with immune checkpoint inhibitors

Li, Y., Zhao, J., Wang, Y., Xu, Y., Li, R., Zhao, Y., Dong, X., Yao, X., & Li, Y. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.11.005 · Cited by 14 · see citing works

Expression of miRNA-146b-5p in patients with thyroid cancer in combination with Hashimoto's disease and its clinical significance

Li, N., Liu, X., Han, L., Zhou, R., Yan, J., Zhao, G., & Liu, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.10173 · Cited by 12 · see citing works

PD‐1‐induced proliferating T cells exhibit a distinct transcriptional signature

Strazza, M., Bukhari, S., Tocheva, A. S., & Mor, A. (2021) · Immunology · doi:10.1111/imm.13388 · Cited by 9 · see citing works

Les dysthyroïdies sous immunothérapie anti-cancéreuse

Anceau, C. C., Abeillon, J., Maillet, D., Borson‐Chazot, F., & Disse, E. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.10.005 · Cited by 9 · see citing works

Correlation between different levels of thyroid autoantibodies and immune checkpoint inhibitor-associated thyroid dysfunction

Jiao, Y., Xu, M., & Rao, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1620718 · Cited by 6 · see citing works

Risk factors of immune-related endocrine toxicities in non-small cell lung cancer patients treated with pembrolizumab and its impact on patient outcomes: a multicenter retrospective study

Zhang, H., Zheng, J., Ren, C., Ye, C., Wu, X. O., Lv, X., Li, Y., Zhou, J., & Zhou, J. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03570-8 · Cited by 6 · see citing works

Risk factors and outcomes of thyroid immune-related adverse events following PD-1/PD-L1 inhibitors treatment in a large tertiary Chinese center

Gong, W., Zheng, E., Liu, M., Han, Y., Lyu, Z., & Guo, Q. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01986-1 · Cited by 5 · see citing works

Dynamic follow-up of the effects of programmed death 1 inhibitor treatment on thyroid function and sonographic features in patients with hepatocellular carcinoma

Zheng, X., Xiao, H., Long, J., Wei, Q., Liu, L., Zan, L., & Ren, W. (2022) · Endocrine Connections · doi:10.1530/ec-22-0065 · Cited by 5 · see citing works

Clinical Significance of Thyroid Autoantibodies in Differential Diagnosis and Predicting the Course of Programmed Cell Death Protein-1 Inhibitor-Induced Thyroid Dysfunction

Li, L., Ding, X., Zhang, X., Kong, S., & Chen, M. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.08.012 · Cited by 2 · see citing works

Thyroid disorders induced by immune checkpoint inhibitors therapy of malignant tumors

Глибка, А. А., Mazurina, N. V., Саранцева, К. А., Харкевич, Г. Ю., Лактионов, К. К., Troshina, E. A., & Mel'nichenko, G. A. (2022) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2022-50-020 · Cited by 1 · see citing works

Primary Incidence of Autoimmune Tyroiditis in the Republic of Belarus and Radiation Factor

Рожко, В. А., Veyalkin, I. V., & Михайловна, Ш. Т. (2020) · Medical Radiology and radiation safety · doi:10.12737/1024-6177-2020-65-2-27-33 · Cited by 1 · see citing works

Nivolumab

(2018) · Reactions Weekly · doi:10.1007/s40278-018-54825-8

CD4 + T cells are essential for the development of destructive thyroiditis induced by anti–PD-1 antibody in thyroglobulin-immunized mice

Yasuda, Y., Iwama, S., Sugiyama, D., Okuji, T., Kobayashi, T., Ito, M., Okada, N., Enomoto, A., Ito, S., Yan, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb7495 · Cited by 87 · see citing works

Cytophilic anti-thyroglobulin antibody and antibody-dependent macrophage-mediated cytotoxicity in Hashimoto’s thyroiditis

満永, 幹. (1987) · Institutional Repositories DataBase (IRDB)

The role of anti-DNA antibodies in pathogenesis of Hashimoto's thyroiditis

Vagapova, G. R., & Саттарова, Л. И. (2009) · Cited by 1 · see citing works

Increased circulating Tfh17 and PD-1+Tfh cells are associated with autoantibodies in Hashimoto’s thyroiditis

Zhao, J., Chen, Y., Zhao, Q. S., Shi, J., Yang, W., Zhu, Z., Yu, W., Guan, J., Song, Y., Wu, H., et al. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1516761 · Cited by 25 · see citing works

High potential to tumor necrosis factor (TNF-) production of thyroid infiltrating T lymphocytes in Hashimoto’s thyroiditis: a peculiar feature of destructive thyroid autoimmunity.

DEL PRETE, G., ROMAGNANI, S., Tiri, A., Carli, M. D., Mariotti, S., Pinchera, A., Chrétien, I., & Ricci, M. (1989) · Florence Research (University of Florence)